{
    "applicationNumber": "BR 11 2022 005114-0",
    "filingDate": "02/10/2020",
    "grantDate": null,
    "title": "ANTICORPO, COMPOSI\u00c7\u00c3O FARMAC\u00caUTICA, M\u00c9TODOS PARA TRATAR C\u00c2NCER E PARA PRODUZIR UM CONJUGADO ANTICORPO-F\u00c1RMACO E UM ANTICORPO, \u00c1CIDO NUCLEICO, VETOR, C\u00c9LULA HOSPEDEIRA, E, CONJUGADO ANTICORPO-F\u00c1RMACO",
    "nationalPhaseDate": [
        "18/03/2022"
    ],
    "internationalApplication": {
        "pctNumber": "PCT US2020/054037",
        "pctDate": "02/10/2020",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "62/910,988",
            "priorityDate": "04/10/2019"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2673"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2685"
        }
    ],
    "inventors": [
        "BYRON HUA KWAN",
        "HEATHER VAN EPPS",
        "ANDREW WAIGHT",
        "SCOTT JEFFREY",
        "RYAN LYSKI"
    ],
    "holders": [
        115981
    ],
    "ipcCodes": [
        "A61P 35/00",
        "C07K 16/28",
        "A61K 47/68"
    ]
}